Microtome Global Market Report 2025

The microtome market size has grown strongly in recent years. It will grow from $0.24 billion in 2024 to $0.26 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to rising awareness of early diagnosis, the increasing demand for biopsies, the growing geriatric population, the rising demand for microtomes, and the increasing prevalence of cancer.

The microtome market size is expected to see strong growth in the next few years. It will grow to $0.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth during the forecast period can be attributed to the rising prevalence of chronic diseases, an increasing elderly population, a growing occurrence of oncological disorders, the rising adoption of microtomes in neuroscience, and the expansion of precision medicine. Key trends expected include advancements in automation, motorized microtomes with programmable features, the introduction of diamond-coated blades, integration with imaging systems, and developments in high-resolution sectioning.

The increasing prevalence of oncological disorders is expected to drive the growth of the microtome market in the coming years. Oncological disorders encompass diseases characterized by the uncontrolled growth and spread of abnormal cells, often resulting in cancer. Several factors contribute to the rising prevalence of these disorders, including an aging population, greater exposure to environmental carcinogens, unhealthy lifestyles, and genetic predispositions. Microtomes play a crucial role in pathology by enabling precise tissue slicing, allowing for the examination of cancerous cells and the determination of tumor type and progression. For instance, in February 2024, the World Health Organization, an international public health organization based in Switzerland, reported that nearly 20 million new cancer cases were recorded in 2022, leading to approximately 10 million deaths. Projections indicate that the annual incidence of cancer could increase to 35 million by 2050, representing a 77% rise from 2022 figures. As a result, the growing prevalence of oncological disorders is fueling the expansion of the microtome market.

Leading companies in the microtome market are concentrating on the development of advanced tissue sectioning devices to enhance efficiency in laboratory settings and improve outcomes in both clinical and research environments. Tissue sectioning devices are essential laboratory tools that produce precise, uniform tissue slices for histology, research, and diagnostics. For example, in February 2023, Precisionary Instruments, a US-based microtome manufacturer, introduced a new line of rotary microtomes. These models feature a heavy, stable core ideal for serial sectioning, ensuring consistent results with large sample sizes. The RF-600 manual model includes two specimen clamp holders for different cassette sizes, while the RF-800 and RF-1000 models incorporate LCD touchscreen controls. The RF-1000 model also offers fully automated cutting capabilities, which can be operated via touchscreen, control panel, or foot pedal for enhanced efficiency. These microtomes are particularly well-suited for sectioning paraffin-embedded tissue in histology studies.

In January 2023, Green Leaf Scientific, an Ireland-based provider of laboratory tools and research instruments, partnered with Precisionary Instruments LLC to introduce tissue sectioning equipment to life science laboratories across Europe. This collaboration aims to integrate Precisionary’s advanced tissue-slicing solutions with Green Leaf Scientific’s sales expertise, customer service, and local market knowledge to foster growth and advance tissue slice research in Europe. Precisionary Instruments LLC is a US-based company specializing in the design and manufacturing of tissue slicers and microtomes.

Major players in the microtome market are Cardinal Health Inc., Leica Biosystems Nussloch GmbH, Sakura Finetek Inc., RWD Life Science Co. Ltd., SM Scientific Instruments Pvt. Ltd., Narang Medical Limited, AGD Biomedicals Pvt. Ltd., Diapath S.p.A., Milestone Medical, Boeckeler Instruments Inc., SLEE Medical GmbH, microTec Laborgeräte GmbH, Campden Instruments, Precisionary Instruments LLC, Jinhua YIDI Medical Appliance Co. Ltd., Medimeas, Histo-Line Laboratories, MEDITE Medical GmbH, Erma Inc., CellPath Ltd., Laboid International.

North America was the largest region in the microtome market in 2024. The regions covered in microtome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the microtome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A microtome is a laboratory instrument designed to cut thin sections of materials, particularly biological tissue, for microscopic analysis. This device ensures the precise and uniform slicing of samples, allowing for high-quality imaging and accurate examination under a microscope.

The primary product categories of microtomes include instruments and accessories. Microtome instruments are specialized devices used to cut thin slices of biological samples for microscopic study. These instruments utilize various technologies, such as fully automated, semi-automated, and manual, for applications including disease diagnosis and medical research. They are used by a range of end-users, including hospitals, clinical and diagnostic laboratories, academic research centers, and others.

The microtomes market research report is one of a series of new reports that provides microtomes market statistics, including the microtomes industry global market size, regional shares, competitors with the microtomes market share, detailed microtomes market segments, market trends, and opportunities, and any further data you may need to thrive in the microtomes industry. This microtomes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microtome market consists of sales of sliding microtomes, cryostat microtomes, sledge microtomes, and ultra microtomes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.